← Back to Catalog
Cagrilintide vial
Cagrilintide
5mg
Clinician Use Only Peptide
For Clinician Use Only
Dispense Under Licensed Oversight
Clinician Only
Metabolic & Foundational

Cagrilintide

Cagrilintide is a long-acting amylin analogue designed to reduce appetite, slow gastric emptying, and support sustained weight loss. It works through a separate pathway to enhance satiety and improve metabolic control.

Available Vials
Delivery
Subcutaneous Injection
Starting Dose
0.1mg to 0.3mg once weekly
Titration
Increase slowly to 0.6mg–1.2mg weekly based on tolerance
Sourcing
Compounded in USA
Pricing

Clinic pricing and patient margins are available to verified clinicians.

Sign in to get pricing
Clinician access

Sign in to view full clinical details

Reconstitution, contraindications, clinic pricing, patient handouts, monitoring cadence, and drug interactions are available to verified clinicians.